GlassScriptPhysician profile
Eric D Aviles
NPI 1093818924
$22,101.83
in general payments reported to CMS, 2019-2025
17 companies · $3,048 in 2025
The $3,048 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,042 · 2020: $1,818 · 2021: $689 · 2022: $3,071 · 2023: $6,917 · 2024: $3,517 · 2025: $3,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Food and Beverage: $5,007 · Travel and Lodging: $3,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Food and Beverage | $5,006.93 |
| Travel and Lodging | $3,224.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,960.62 | 2021-2025 | Watchman Flx, Watchman, Vigilant X4 Crt-D |
| Edwards Lifesciences Corporation | $4,611.05 | 2023-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,641.46 | 2019-2025 | Portico, Mitraclip, Amplatzer Amulet |
| Pfizer INC. | $1,921.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,114.48 | 2019-2025 | Jardiance |
| Amgen INC. | $650.74 | 2019-2025 | Repatha, Evenity, Repatha |
| Medtronic Vascular, INC. | $596.27 | 2019-2020 | |
| Medtronic, INC. | $573.86 | 2019-2025 | Pulseselect, Cobalt Dr Mri Surescan, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.83 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $222.61 | 2021-2024 | Verquvo, Januvia, Winrevair |
| Astrazeneca Pharmaceuticals LP | $208.32 | 2019-2025 | Brilinta, Lokelma, Wainua |
| E.R. Squibb & Sons, L.L.C. | $89.39 | 2022-2025 | Camzyos |
| Siemens Medical Solutions USA, INC. | $83.01 | 2019 | |
| Bayer Puerto Rico INC. | $42.97 | 2025 | Kerendia |
| Bridgebio Pharma, INC. | $40.00 | 2025 | Attruby |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pbg Puerto Rico LLC | $18.95 | 2019 | |
| Pfizer Pharmaceuticals LLC | $15.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Aviles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.